HOUSTON - eTradeWire -- Elabscience®, a leading global biotechnology company dedicated to providing high-quality reagents and services for life science research, today announced a major technological upgrade to its antibody product line. The initiative introduces recombinant rabbit monoclonal antibody technology, representing a significant step forward in antibody innovation, production efficiency, and performance consistency.

This upgrade reflects Elabscience's continued commitment to scientific excellence and innovation, in response to the growing global demand for high-performance and highly reproducible antibody reagents.

Driving Innovation with Recombinant Antibody Technology

With the rapid advancement of recombinant antibody engineering, Elabscience has fully integrated recombinant rabbit monoclonal antibody technology into its R&D and manufacturing processes. This new platform offers outstanding specificity, batch-to-batch consistency, stability, and scalability, addressing long-standing challenges associated with traditional hybridoma-derived antibodies.

"At Elabscience, we continuously strive to improve the scientific reliability of antibody-based research," said Dr. Lan, Director of Antibody Research and Development at Elabscience®. "By introducing recombinant rabbit monoclonal antibodies, we're empowering researchers with higher-quality, more consistent, and more efficient tools to accelerate discovery in fields such as immunology, oncology, and neuroscience."

More on eTradeWire News

• Fractional CMOs Reach the Factory Floor as Industrial Demand Climbs
• Ventosa Vineyards Earns Seven Medals at 2026 New York Wine Classic
• Inner Healer Summit Brings Leading Voices in Healing, Wellness and More Together in Atlanta
• Reggae on the River's Landmark 37th Year
• I Got The Power Washer LLC Provides Professional Pressure Washing Services in Cincinnati, Ohio

Highlights of the Technology Upgrade

1. Advanced Molecular Design
● Utilizes humanized frameworks with rabbit variable region recombination, reducing heterologous immunogenicity, ideal for long-term in vivo studies.
● Combines phage display library screening with epitope prediction algorithms, enabling the generation of high-affinity antibodies (KD < 10⁻⁹ M) against complex conformational antigens such as GPCRs and ion channels.

2. Enhanced Production Process
● Employs CHO-S suspension cell culture in serum-free media, achieving batch yields over 500 mg, a 20-fold efficiency improvement compared with traditional hybridoma methods.
● Utilizes continuous flow chromatography purification, ensuring endotoxin levels below 0.1 EU/mg and meeting rigorous standards for preclinical research.

3. Stringent Quality Control
● Performs accelerated stability testing (activity retention > 90% after 14 days at 37°C).
● All batches undergo LC-MS peptide mapping and SEC-HPLC purity testing, with monomer content ≥ 98%.

Performance Comparison

Product Type: Anti-β-actin Antibody
Rabbit Polyclonal (Old): Inter-batch CV 12-15%

More on eTradeWire News

• Eagle Rankers LLC Expands Digital Marketing and SEO Services for Cincinnati Businesses
• She Had a System. She Never Published It. Her Granddaughter Broke the Cycle
• Sine Nomine Associates Inc. contributes to firefighting effort in western states
• BWHI Releases Report Centering Black Women in the National Menopause Policy
• Convergence AI Launches Private Dedicated AI Servers for Security-Conscious Businesses

Recombinant Rabbit Monoclonal (New): Inter-batch CV < 3%

Product Type: Anti-PD-1 Antibody
Rabbit Polyclonal (Old): WB detection requires 1:500 dilution
Recombinant Rabbit Monoclonal (New): WB detection possible at up to 1:5000 dilution

Product Type: Anti-GFAP Antibody
Rabbit Polyclonal (Old): Supports IHC application only
Recombinant Rabbit Monoclonal (New): Compatible with IHC/ICC/IF multiple scenarios

These advancements deliver greater sensitivity, reproducibility, and versatility across research applications.

Contact

Elabscience Biotechnology Inc.
🌐 https://www.elabscience.com
📧 orders@elabscience.com

About Elabscience®
Elabscience® develops and produces high-quality reagents, including ELISA kits, antibodies, recombinant proteins, and assay kits to support global research in immunology, oncology, metabolism, and neuroscience.